Qiagen N.V. (ETR:QIA)
Germany flag Germany · Delayed Price · Currency is EUR
37.02
-0.59 (-1.57%)
Apr 25, 2025, 5:35 PM CET

Qiagen Company Description

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories.

It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing.

The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions.

It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services.

The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers.

The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Qiagen N.V.
Qiagen logo
Country Netherlands
Founded 1984
Industry Diagnostics & Research
Sector Healthcare
Employees 5,396
CEO Thierry Bernard

Contact Details

Address:
Hulsterweg 82
Venlo, 5912 PL
Netherlands
Phone 31 77 355 6600
Website qiagen.com

Stock Details

Ticker Symbol QIA
Exchange Deutsche Börse Xetra
Fiscal Year January - December
Reporting Currency USD
ISIN Number NL0015002CX3
SIC Code 3826

Key Executives

Name Position
Thierry Bernard Chief Executive Officer, MD and Member of Management Board
Dr. Roland Sackers Chief Financial Officer, MD and Member of Management Board
Antonio Santos Senior Vice President and Head of Global Operations
John Gilardi Vice President of Corporate Communications and Investor Relations
Dr. Dominic John Vice President of Marketing and Product Management
Stephany Foster Senior Vice President and Head of Human Resources
Dr. Thomas Schweins Senior Vice President of Life Science Business Area
Dr. Thomas Theuringer Senior Director and Head of External Communications
Jean-Pascal Viola Senior Vice President and Head of Corporate Strategy and Business Development
Dr. Jonathan G. Sheldon Ph.D. Senior Vice President and Head of the QIAGEN Digital Insights Business Area